News reports of first responder’s adverse reactions to synthetic opioids like fentanyl have led to concerns about the risks of the substances for court personnel. This briefing paper from the National Judicial Opioid Task Force discusses the risks of fentanyl and similar substances to court personnel and recommends
Treatment courts have established themselves as a proven alternative to incarceration for individuals with substance use disorders and justice involvement. Unfortunately, individuals charged in federal court rarely have access to treatment court programs. In 2015, judges in Montana created an memorandum of understanding (MOU) to allow for
This guide serves as a resource for judges on how to take a leadership role in their community or region in convening stakeholders to collaborate on solutions to the opioid crisis.
This 2019 publication from the National Judicial Opioid Task Force focuses on how judges and the judicial system can help reshape the child welfare system in the midst of the opioid epidemic by strengthening families and focusing on prevention. The report includes a discussion of the Family First Prevention Services Act and how the law affects judicial decision-making.
This 2019 publication by SAMHSA discusses the challenges to providing medication assisted treatment in criminal justice settings such as correctional facilities, reentry programs, and treatment courts and provides policy makers with strategies to overcome these challenges. Funding Source: Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
This report from the National Judicial Opioid Task Force provides information about medication assisted treatment (MAT) for opioid use disorder (OUD) . It includes a description of MAT medications and legal considerations about MAT.